Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Emerging from the University of Exeter, augmented depression therapy (ADepT) proposes a novel approach in depression treatment, potentially surpassing the current gold standard, cognitive behavioral therapy (CBT), in both efficacy and cost-efficiency. This ground-breaking therapy, focusing on both symptom reduction and well-being enhancement, offers promising implications for the future of mental health care.
Psychiatry July 19th 2023
Addiction Professional
SIVAD Diagnostic Medical Group’s novel drug testing strips, HarmGuard FX, are making strides in harm reduction, beginning in Delaware. These strips, a part of the wider Harm Stopper Program, signal a potential turning point in the battle against the national opioid crisis.
Psychiatry July 11th 2023
Annals of Internal Medicine
As we grapple with the opioid crisis, this comprehensive study offers crucial insights into the intersection of state medical cannabis laws and chronic noncancer pain treatment, and posits no significant changes in pain treatment due to these laws.
Pain Medicine July 11th 2023
Recent research uncovers the psychological roots of “conspiratorial ideation,” offering fresh insights into the motivations and personality traits that fuel conspiracy theories, and paving the way for more effective interventions. Explore this in-depth analysis for a deeper understanding of the complex psychology of conspiracy theories.
ReachMD
Discover how prucalopride, typically used as a laxative, is showing promise as a cognitive enhancer in recent neurological research. Learn more about its potential implications for treating cognitive deficits in mood disorders.
Neurology July 5th 2023
As tDCS devices gain popularity for at-home use, physicians must navigate the complex terrain of this emerging trend, balancing the devices’ potential benefits with the stark reality of unverified efficacy and potential side effects.